Virology News and Research

Latest Virology News and Research

Cervical cancer vaccine may protect females from post-surgical recurrence

A vaccine designed to prevent cervical cancer also may protect females from post-surgical recurrence of the disease, according to researchers at the University of Alabama at Birmingham (UAB).

17 Mar 2010

Can preventative vaccines curb the rising numbers of HIV cases?

According to a recent United Nations study, HIV infection rates among high-risk groups such as gays, drug users and sex workers are on the rise around the world.

17 Mar 2010

Black children less likely to develop shingles after receiving chickenpox vaccine

Black children are less likely than white or Asian children to develop shingles (herpes zoster) after receiving the varicella vaccine to prevent chickenpox, reports a study in the March issue of The Pediatric Infectious Disease Journal.

17 Mar 2010

Sidibe calls for a 'prevention revolution' to fight HIV/AIDS

UNAIDS head Michel Sidibe on Monday called for a "prevention revolution" to fight HIV/AIDS and addressed laws he says make high-risk groups more vulnerable to the disease, the Associated Press reports. Speaking to a group of journalists in New York, Sidibe "said 'it is unacceptable' that 85 countries still have laws criminalizing same sex relations among adults, including seven that impose the death penalty for homosexual practices," the news service writes.

17 Mar 2010

Gardasil vaccine may protect women from post-surgical recurrence of cervical cancer

A vaccine designed to prevent cervical cancer also may protect females from post-surgical recurrence of the disease, according to researchers at the University of Alabama at Birmingham.

17 Mar 2010

International Liver Congress 2010: Achillion Pharmaceuticals' protease inhibitor abstract accepted for presentation

Achillion Pharmaceuticals, Inc., a leader in the discovery and development of treatments for the most challenging infectious diseases, today announced that its abstract titled "Virological Response, Safety, and Pharmacokinetic Profile Following Single- and Multiple-Dose Administration of ACH-0141625 Protease Inhibitor to Healthy Volunteers and HCV Genotype-1 Patients" has been accepted as a late breaking poster presentation at the International Liver Congress™ 2010 being held April 14-18 in Vienna, Austria.

17 Mar 2010

Booster shot appears to improve TB resistance in previously vaccinated adults

A booster shot appears to improve tuberculosis (TB) resistance in previously vaccinated adults, according to new research in South Africa.

17 Mar 2010

Vertex Pharmaceuticals' telaprevir and VX-222 HCV inhibitor abstracts accepted for presentation at 45th EASL meeting

Vertex Pharmaceuticals Incorporated today announced that multiple abstracts related to the hepatitis C virus (HCV) protease inhibitor telaprevir and the HCV polymerase inhibitor VX-222 were accepted for presentation at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL) in Vienna, Austria, April 14-18, 2010.

17 Mar 2010

Tolerx publishes follow-up data from study of otelixizumab therapy for new onset T1DM patients

Tolerx, Inc., today announced the publication in Diabetologia, the journal of the European Association for the Study of Diabetes, of the four-year follow-up clinical data from new onset type 1 diabetes (T1DM) patients (age 12-39) who received a single short course of therapy with otelixizumab (ChAglyCD3).

16 Mar 2010

Novavax reports net loss of $14M for fourth-quarter of 2009

StockPreacher.com announces an investment report featuring Novavax Inc. (Nasdaq:NVAX). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

16 Mar 2010

Fraunhofer USA CMB receives $4.395M award from DARPA to develop H1N1 influenza vaccine

Fraunhofer USA Center for Molecular Biotechnology announced today that it has received a $4.395 million award from the Defense Advanced Research Projects Agency to develop a vaccine against H1N1 influenza virus using its plant-based production platform.

16 Mar 2010

National childhood varicella vaccination program reduces chickenpox hospitalization rates

Since the varicella vaccine was introduced in the mid-1990s, the number of patients receiving medical care for chickenpox in the United States has decreased sharply—particularly among children, according to a study in the March issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

16 Mar 2010

Banana lectin discovery may lead to potential new treatments for preventing sexual transmission of HIV

A potent new inhibitor of HIV, derived from bananas, may open the door to new treatments to prevent sexual transmission of HIV, according to a University of Michigan Medical School study published this week.

16 Mar 2010

Obesity limits body's ability to fight infections

Obesity may limit the body's ability to develop immunity to influenza viruses, particularly secondary infections, by inhibiting the immune system's ability to "remember" how it fought off previous similar bouts of illness, according to new research from the University of North Carolina at Chapel Hill.

16 Mar 2010

Opinions: Discrimination against sexual orientation; WFP in Somalia; Haiti's recovery; WHO's policy role

In a Washington Post opinion piece, Desmond Tutu, archbishop emeritus of Cape Town, South Africa, and Nobel Peace Prize recipient, speaks out against efforts to deny individuals "their fundamental rights and freedoms" based on their sexual orientation.

16 Mar 2010

TCAD therapy superior to double combinations and monotherapy against influenza viruses

Adamas Pharmaceuticals, Inc., a privately held company, announced today results from in vivo animal studies and in vitro tests demonstrating that its triple combination antiviral drug (TCAD) therapy is superior relative to double combinations and monotherapy against multiple strains of pandemic and avian influenza viruses. Results of these studies were presented Sunday evening in an oral session at the XII International Symposium on Respiratory Viral Infections being held in Taipei.

15 Mar 2010

StockPreacher.com announces investment report featuring GenVec

StockPreacher.com announces an investment report featuring GenVec Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

15 Mar 2010

Nanoparticles provide a targeted version of photothermal therapy for cancer

In a lecture he delivered in 1906, the German physician Paul Ehrlich coined the term Zuberkugel, or "magic bullet," as shorthand for a highly targeted medical treatment.

15 Mar 2010

Ardea Biosciences' revenues total $8.3M for three months ended December 31, 2009

Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.

12 Mar 2010

Flu infection during pregnancy may increase risk of schizophrenia in offspring

Rhesus monkey babies born to mothers who had the flu while pregnant had smaller brains and showed other brain changes similar to those observed in human patients with schizophrenia, a study at the University of Wisconsin-Madison in collaboration with the University of North Carolina at Chapel Hill has found.

12 Mar 2010

Virology News and Research

Latest Virology News and Research

Cervical cancer vaccine may protect females from post-surgical recurrence

Can preventative vaccines curb the rising numbers of HIV cases?

Black children less likely to develop shingles after receiving chickenpox vaccine

Sidibe calls for a 'prevention revolution' to fight HIV/AIDS

Gardasil vaccine may protect women from post-surgical recurrence of cervical cancer

International Liver Congress 2010: Achillion Pharmaceuticals' protease inhibitor abstract accepted for presentation

Booster shot appears to improve TB resistance in previously vaccinated adults

Vertex Pharmaceuticals' telaprevir and VX-222 HCV inhibitor abstracts accepted for presentation at 45th EASL meeting

Tolerx publishes follow-up data from study of otelixizumab therapy for new onset T1DM patients

Novavax reports net loss of $14M for fourth-quarter of 2009

Fraunhofer USA CMB receives $4.395M award from DARPA to develop H1N1 influenza vaccine

National childhood varicella vaccination program reduces chickenpox hospitalization rates

Banana lectin discovery may lead to potential new treatments for preventing sexual transmission of HIV

Obesity limits body's ability to fight infections

Opinions: Discrimination against sexual orientation; WFP in Somalia; Haiti's recovery; WHO's policy role

TCAD therapy superior to double combinations and monotherapy against influenza viruses

StockPreacher.com announces investment report featuring GenVec

Nanoparticles provide a targeted version of photothermal therapy for cancer

Ardea Biosciences' revenues total $8.3M for three months ended December 31, 2009

Flu infection during pregnancy may increase risk of schizophrenia in offspring

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production